Both in Biotechnology
Vor Biopharma vs Taysha Gene Therapies
Over the past year VOR returned −14.1% and TSHA returned −10.3%; their daily moves had a correlation of 0.20.
VOR −14.1% TSHA −10.3%Growth of $1, one year, split-adjusted
| Metric | VOR | TSHA |
|---|---|---|
| Price | $19.25 | $4.00 |
| Market cap | $1.18B | $1.30B |
| Today | −2.19% | −3.15% |
| 1 month | +3.0% | −13.6% |
| 6 months | +30.9% | −39.8% |
| Year to date | +47.2% | −27.3% |
| 1 year | −23.0% | −18.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 0.9× | — |
| Price / sales | — | 237.6× |
| Net cash | $481.6M | $406.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.8% | 57.9% |
| Short % of float | 17.6% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).